EPRX
Eupraxia Pharmaceuticals
EPRX
EPRX
11 hedge funds and large institutions have $7.09M invested in Eupraxia Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.92% more ownership
Funds ownership: 5.13% → 6.05% (+0.92%)
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$526K | |
| 2 | +$343K | |
| 3 | +$196K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$76.1K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$39.4K |
Top Sellers
| 1 | -$33.3K | |
| 2 | -$31.3K | |
| 3 | -$14.7K | |
| 4 |
Raymond James Financial
St Petersburg,
Florida
|
-$1.57K |